-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
GeneDx Holdings Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- GeneDx Holdings Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.78M, a 81.9% increase year-over-year.
- GeneDx Holdings Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$57.7M, a 88% increase year-over-year.
- GeneDx Holdings Corp. annual Operating Income (Loss) for 2023 was -$181M, a 73% increase from 2022.
- GeneDx Holdings Corp. annual Operating Income (Loss) for 2022 was -$668M, a 49.6% decline from 2021.
- GeneDx Holdings Corp. annual Operating Income (Loss) for 2021 was -$446M, a 84.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)